学術論文　2019

  1. Hayakawa, H.; Fukasawa, M.; Sato, T.; Takano, S.; Kadokura, M.; Shindo, H.; Takahashi, E.; Hirose, S.; Kawakami, S.; Fukasawa, Y.; et al. Carcinoembryonic antigen level in the pancreatic juice is effective in malignancy diagnosis and prediction of future malignant transformation of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol 2019, 54, 1029–1037, doi:10.1007/s00535-019-01592-8.
  2. Kawaida, H.; Kono, H.; Amemiya, H.; Hosomura, N.; Watanabe, M.; Saito, R.; Maruyama, S.; Shimizu, H.; Furuya, S.; Akaike, H.; et al. Stratification of Prognosis in Patients With Ampullary Carcinoma After Surgery by Preoperative Platelet-to-lymphocyte Ratio and Conventional Tumor Markers. Anticancer Res. 2019, 39, 6923–6929, doi:10.21873/anticanres.13913.
  3. Kawai-Kitahata, F.; Asahina, Y.; Kaneko, S.; Tsuchiya, J.; Sato, A.; Miyoshi, M.; Tsunoda, T.; Inoue-Shinomiya, E.; Murakawa, M.; Nitta, S.; et al. Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma-like area and metachronous hepatocellular carcinoma. Hepatol. Res. 2019, 49, 1466–1474, doi:10.1111/hepr.13403.
  4. Kawakami, S.; Fukasawa, M.; Shimizu, T.; Ichikawa, S.; Sato, T.; Takano, S.; Kadokura, M.; Shindo, H.; Takahashi, E.; Hirose, S.; et al. Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm. Medicine (Baltimore). 2019, 98, e18039, doi:10.1097/MD.0000000000018039.
  5. Wang, W.; Tsuchiya, K.; Kurosaki, M.; Yasui, Y.; Inada, K.; Kirino, S.; Yamashita, K.; Sekiguchi, S.; Hayakawa, Y.; Osawa, L.; et al. Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice. Cancers (Basel). 2019, 11, doi:10.3390/cancers11101517.
  6. Tsukui, Y.; Yamaguchi, T.; Maekawa, S.; Takano, S.; Sato, T.; Enomoto, N. Dickkopf-4 gene expression is associated with differentiation and lymph node metastasis in colorectal cancer. JGH open  an open access J. Gastroenterol. Hepatol. 2019, 3, 409–416, doi:10.1002/jgh3.12177.
  7. Takano, S.; Fukasawa, M.; Kadokura, M.; Shindo, H.; Takahashi, E.; Hirose, S.; Fukasawa, Y.; Kawakami, S.; Hayakawa, H.; Maekawa, S.; et al. Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer. Pancreas 2019, 48, 1032–1040, doi:10.1097/MPA.0000000000001371.
  8. Takada, H.; Kurosaki, M.; Tsuchiya, K.; Komiyama, Y.; Itakura, J.; Takahashi, Y.; Nakanishi, H.; Yasui, Y.; Tamaki, N.; Maeyashiki, C.; et al. Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma. Cancers (Basel). 2019, 11, doi:10.3390/cancers11091256.
  9. Mateos, R.N.; Nakagawa, H.; Hirono, S.; Takano, S.; Fukasawa, M.; Yanagisawa, A.; Yasukawa, S.; Maejima, K.; Oku-Sasaki, A.; Nakano, K.; et al. Genomic analysis of pancreatic juice DNA assesses malignant risk of intraductal papillary mucinous neoplasm of pancreas. Cancer Med. 2019, 8, 4565–4573, doi:10.1002/cam4.2340.
  10. Tamaki, N.; Higuchi, M.; Kurosaki, M.; Kirino, S.; Osawa, L.; Watakabe, K.; Wang, W.; Okada, M.; Shimizu, T.; Takaura, K.; et al. Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease. Sci. Rep. 2019, 9, 10109, doi:10.1038/s41598-019-46172-1.
  11. Tamaki, N.; Higuchi, M.; Kurosaki, M.; Kirino, S.; Osawa, L.; Watakabe, K.; Wang, W.; Okada, M.; Shimizu, T.; Takaura, K.; et al. Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals. J. Viral Hepat. 2019, 26, 893–899, doi:10.1111/jvh.13103.
  12. Yoshida, T.; Yamaguchi, T.; Maekawa, S.; Takano, S.; Kuno, T.; Tanaka, K.; Iwamoto, F.; Tsukui, Y.; Kobayashi, S.; Asakawa, Y.; et al. Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing. Gastric cancer  Off. J. Int. Gastric Cancer Assoc.  Japanese Gastric Cancer Assoc. 2019, 22, 742–750, doi:10.1007/s10120-019-00926-y.
  13. Hirose, S.; Fukasawa, M.; Takano, S.; Kadokura, M.; Shindo, H.; Takahashi, E.; Yokota, Y.; Fukasawa, Y.; Kawakami, S.; Hayakawa, H.; et al. Safety and Efficacy of a Small J-Tipped Guidewire for Pancreatic Duct Endoscopic Intervention. Can. J. Gastroenterol. Hepatol. 2019, 2019, 8947614, doi:10.1155/2019/8947614.
  14. Suzuki, Y.; Maekawa, S.; Komatsu, N.; Sato, M.; Tatsumi, A.; Miura, M.; Matsuda, S.; Muraoka, M.; Nakakuki, N.; Amemiya, F.; et al. HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers. PLoS One 2019, 14, e0212559, doi:10.1371/journal.pone.0212559.
  15. Takada, H.; Kurosaki, M.; Nakanishi, H.; Takahashi, Y.; Itakura, J.; Tsuchiya, K.; Yasui, Y.; Tamaki, N.; Takaura, K.; Komiyama, Y.; et al. Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures. PLoS One 2019, 14, e0211122, doi:10.1371/journal.pone.0211122.
  16. Ichikawa, S.; Motosugi, U.; Enomoto, N.; Onishi, H. Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data. Eur. Radiol. 2019, 29, 1013–1021, doi:10.1007/s00330-018-5640-7.
  17. Takano, S.; Fukasawa, M.; Shindo, H.; Takahashi, E.; Hirose, S.; Fukasawa, Y.; Kawakami, S.; Hayakawa, H.; Yokomichi, H.; Kadokura, M.; et al. Risk factors for perforation during endoscopic retrograde cholangiopancreatography in post-reconstruction intestinal tract. World J. Clin. cases 2019, 7, 10–18, doi:10.12998/wjcc.v7.i1.10.
  18. Miura, Y.; Iwamoto, F.; Ishida, Y.; Kuno, T.; Tanaka, K.; Kobayashi, S.; Yoshida, T.; Yamaguchi, T.; Sato, T.; Enomoto, N. [Refractory eosinophilic gastroenteritis with gastritis, duodenal ulcer, and colitis: a case report]. Nihon Shokakibyo Gakkai Zasshi 2019, 116, 668–675, doi:10.11405/nisshoshi.116.668.
  19. Osawa, L.; Shindo, H.; Fukasawa, M.; Takano, S.; Takahashi, E.; Hirose, S.; Sato, T.; Hosomura, N.; Kawaida, H.; Enomoto, N. [Case of paraganglioma mimicking lymph node metastasis from a pancreatic neuroendocrine neoplasm]. Nihon Shokakibyo Gakkai Zasshi 2019, 116, 80–87, doi:10.11405/nisshoshi.116.80.
  20. Suzuki, Y.; Maekawa, S.; Komatsu, N.; Sato, M.; Tatsumi, A.; Miura, M.; Matsuda, S.; Muraoka, M.; Nakakuki, N.; Shindo, H.; et al. Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and  high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma. Hepatol. Res. 2019, 49, 51–63, doi:10.1111/hepr.13277.